NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Clearance to Proceed with Clinical Trial of NRX-101 in Combination with Robotic-enabled Transcranial Magnetic Stimulation in Patients with Depression an
Go back to NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Clearance to Proceed with Clinical Trial of NRX-101 in Combination with Robotic-enabled Transcranial Magnetic Stimulation in Patients with Depression an| (NASDAQ: NRXP) | Delayed: 3.56 -0.2 (5.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.76 | 52 Week High | $ | |||
| Open | $3.78 | 52 Week Low | $ | |||
| Day High | $3.86 | P/E | N/A | |||
| Day Low | $3.10 | EPS | $ | |||
| Volume | 2,558,328 | |||||
